HomeUR9 • FRA
add
Clinuvel Pharmaceuticals Ltd
Previous close
€6.06
Day range
€5.79 - €6.09
Year range
€4.80 - €7.68
Market cap
501.00M AUD
Avg Volume
422.00
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
In the news
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 18.47M | 3.60% |
Operating expense | 9.42M | 15.53% |
Net income | 5.22M | -25.81% |
Net profit margin | 28.28 | -28.39% |
Earnings per share | — | — |
EBITDA | 7.01M | -16.98% |
Effective tax rate | 28.39% | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 233.00M | 17.55% |
Total assets | 269.70M | 14.18% |
Total liabilities | 20.68M | 9.40% |
Total equity | 249.02M | — |
Shares outstanding | 50.16M | — |
Price to book | 1.22 | — |
Return on assets | 6.26% | — |
Return on capital | 6.77% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 5.22M | -25.81% |
Cash from operations | 6.26M | -4.77% |
Cash from investing | -462.59K | 96.92% |
Cash from financing | -1.36M | 7.87% |
Net change in cash | 4.06M | 144.17% |
Free cash flow | 4.12M | -21.45% |
About
Founded
1999
Website
Employees
16
